Similar Articles
241 Construction and validation of somatic mutation-derived long non-coding RNAs signatures of genomic instability to predict prognosis of hepatocellular carcinoma
242 Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status
243 Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma
244 Comprehensive prognostic and immune analysis of sterol O-acyltransferase 1 in patients with hepatocellular carcinoma
245 Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis
246 MicroRNAs in hepatocellular carcinoma treatment: Charting the path forward
247 Liver transplantation for hepatocellular carcinoma in India: Are we ready for 2040?
248 Chinese herbal medicine decreases incidence of hepatocellular carcinoma in diabetes mellitus patients with regular insulin management
249 Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy
250 Risk of cardiovascular death in patients with hepatocellular carcinoma based on the Fine-Gray model
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA